Dimensional Fund Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,349
Closed -$40K 3609
2021
Q3
$40K Hold
1,349
﹤0.01% 3483
2021
Q2
$46K Sell
1,349
-63
-4% -$2.35K ﹤0.01% 3441
2021
Q1
$59K Buy
1,412
+568
+67% +$35.3K ﹤0.01% 3386
2020
Q4
$51K Sell
844
-152
-15% -$16.5K ﹤0.01% 3316
2020
Q3
$133K Sell
996
-733
-42% -$123K ﹤0.01% 3243
2020
Q2
$292K Sell
1,729
-871
-34% -$145K ﹤0.01% 3166
2020
Q1
$374K Sell
2,600
-580
-18% -$177K ﹤0.01% 3107
2019
Q4
$1.05M Sell
3,180
-670
-17% -$307K ﹤0.01% 2995
2019
Q3
$1.93M Sell
3,850
-17
-0.4% -$9.59K ﹤0.01% 2862
2019
Q2
$2.35M Buy
3,867
+830
+27% +$509K ﹤0.01% 2860
2019
Q1
$1.85M Buy
3,037
+635
+26% +$346K ﹤0.01% 2911
2018
Q4
$877K Hold
2,402
﹤0.01% 3041
2018
Q3
$1.62M Buy
2,402
+1,026
+75% +$727K ﹤0.01% 2972
2018
Q2
$1.2M Buy
1,376
+929
+208% +$1.06M ﹤0.01% 2993
2018
Q1
$563K Buy
447
+283
+173% +$419K ﹤0.01% 3087
2017
Q4
$245K Buy
+164
New +$259K ﹤0.01% 3192

Other funds holding NBRV

Dimensional Fund Advisors's NBRV Position: Q4 2021 in Review

Dimensional Fund Advisors sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2021, closing a stake of 1,349 shares — an estimated $40K sold.

Dimensional Fund Advisors first reported a position in NBRV in Q4 2017 and held it in 16 quarters. The position peaked at $2.35M in Q2 2019. 34 funds tracked by Wall St. Rank hold NBRV as of Q4 2021.

  • Dimensional Fund Advisors reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,349 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2021, an estimated $40K.
  • Dimensional Fund Advisors first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q4 2017 and held it in 16 quarters.
  • Dimensional Fund Advisors's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $2.35M in Q2 2019.
  • 34 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2021.

Based on Dimensional Fund Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.